Lidocaine vs Bupivacaine Dosing for Local Anesthesia
Lidocaine allows higher maximum doses than bupivacaine: for adults, use up to 7.0 mg/kg of lidocaine with epinephrine versus only 150 mg total (approximately 2 mg/kg) of bupivacaine, regardless of epinephrine addition.
Maximum Dose Guidelines
Adults
Lidocaine 1:
- Without epinephrine: 4.5 mg/kg maximum
- With epinephrine: 7.0 mg/kg maximum
- For multistage procedures (e.g., Mohs surgery): up to 500 mg over several hours
Bupivacaine 2:
- 150 mg maximum for subcutaneous injection (approximately 2 mg/kg for a 70 kg adult)
- 75 mg maximum in regions of high absorption
- This limit applies whether or not epinephrine is added—the epinephrine formulation is limited by total epinephrine content (0.25 mg)
Children
Lidocaine 1:
- Without epinephrine: 1.5-2.0 mg/kg
- With epinephrine: 3.0-4.5 mg/kg
The provided guidelines do not specify pediatric bupivacaine dosing, but the adult restrictions suggest proportionally lower doses should be used.
Key Pharmacologic Differences
Potency: Bupivacaine is 5.7-7 times more potent than lidocaine at equivalent analgesic concentrations 3, which explains the dramatically lower maximum allowable dose.
Onset Time: Lidocaine acts faster (14-20 minutes to complete block) versus bupivacaine alone (21-35 minutes) 4, 5.
Duration of Action:
- Lidocaine provides 2-4 hours of analgesia 6, 5
- Bupivacaine provides 12-14 hours of analgesia 6, 5
- Sensory block duration: lidocaine ~70 minutes versus bupivacaine ~101-128 minutes 7
Clinical Decision Algorithm
For procedures requiring <2 hours of anesthesia with rapid onset:
- Use lidocaine with epinephrine (faster onset, adequate duration, higher safe dose ceiling)
For procedures requiring prolonged postoperative analgesia:
- Use bupivacaine alone (12+ hours of pain control) but accept slower onset (20-35 minutes)
For procedures requiring both rapid onset AND extended analgesia:
- Consider equal-volume mixture of 2% lidocaine with 0.5% bupivacaine 4, 5
- This provides lidocaine-like onset (16-20 minutes) with intermediate duration (8-10 hours)
- The mixture reduces total bupivacaine dose, potentially improving safety margin
Critical Safety Considerations
Always implement these toxicity prevention steps 1, 8:
- Aspirate before each injection to avoid intravascular administration
- Use incremental injections (3-5 mL aliquots for epidural)
- Use the lowest effective dose
- Monitor continuously for early toxicity signs (circumoral numbness, tinnitus, altered mental status)
Common Pitfall: Do not assume epinephrine increases the safe dose of bupivacaine—it does not. The maximum bupivacaine dose remains 150 mg regardless of vasoconstrictor addition 2. In contrast, epinephrine increases lidocaine's safe dose from 4.5 to 7.0 mg/kg 1.
Accumulation Risk: Repeated dosing causes drug accumulation, particularly in debilitated or elderly patients 8. Reduce doses accordingly and extend time intervals between injections.